CORDIS · 852614 · H2020
INFRADYNAMICS Overcoming the Barriers of Brain Cancer Treatment: Targeted and Fully NIR Absorbing Photodynamic Therapy Agents with Extremely Low Molecular Weights and Controlled Lipophilicity
Coordinator: MIDDLE EAST TECHNICAL UNIVERSITY (TR)
Cancer is the second leading cause of death worldwide, accounting for a total of 8.8 million deaths in 2015. Research efforts have resulted in significant increase in 5-year survival rates for some cancer types, however this is not the case in brain cancer. Three fundamental issues are at the core of this reality: 1) High percentage of inoperable brain tumours; 2) Limited number of drugs that can pass through the blood-brain barrier and 3) Absence of effective targeted brain cancer therapies. Photodynamic therapy (PDT) has the potential to be a selective, effective and non-invasive alternativ…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €1.5M awarded to the consortium. The project runs over approximately 6 years from 2019-11-01 to 2025-10-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from TR
see all →- CoCirculation3 — CO-FUNDED Brain Circulation 3101179377 · HORIZON · €9.6M
- TEAM-NANO — Teaming for Capacity Development and Synergies in Micro-nanofabrication and Flexible Electronics for Widespread Impact101136388 · HORIZON · €9.0M
- SHEREC — SAFE, HEALTHY AND ENVIRONMENTAL SHIP RECYCLING101136056 · HORIZON · €8.0M
- CoCirculation2 — CO-FUNDED Brain Circulation Scheme 2801509 · H2020 · €6.2M
- DIAMETER — Demonstration of a sustainable circular-by-design manufacturing system based on additive manufacturing101177422 · HORIZON · €6.0M
- HSMonitor — Pre-commercial Procurement of innovative ICT-enabled monitoring to improve health status and optimise hypertension care856698 · H2020 · €5.9M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-STG funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.5M toward a total project budget of €1.5M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2019-STG.
- Who coordinates the project?
- The project is coordinated by MIDDLE EAST TECHNICAL UNIVERSITY (TR).
- What is the project timeline?
- The project runs from 2019-11-01 to 2025-10-31 — approximately 6 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 852614.